Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Biobusiness Briefs
  • Published:

Trial watch

Global migration of clinical trials

Nature Reviews Drug Discovery volume 13, pages 166–167 (2014)Cite this article

Subjects

Organizations that conduct clinical trials are increasingly using global networks to reduce costs and accelerate recruitment. Because the migration of clinical trials from countries such as the United States to other countries where the health-care infrastructure is less developed has public health, economic, social and ethical implications, we explored a large repository of open-access trial registry data to understand changes in the global distribution of clinical trials.

Clinical trials were classified by geographical region. Over the 2005–2012 period overall, 127,314 (67%) of the 189,213 registered trials were conducted in the United States, Canada or Europe (see Table 2 in Supplementary information S2 (box)). The United States was the single largest country conducting clinical trials, with 58,980 trials (30%). The absolute increase was greatest for the Asian region (489%) and the Latin American/Caribbean region (112%); the smallest increase occurred in the North American region (9%) (Fig. 1b).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Global migration of clinical trials.

Acknowledgements

This research was supported by the Harvard Global Health Institute, the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988), the Program in AIDS Clinical Research Training Grant (T32 AI007433) (to P.K.D.); the US National Institute of Mental Health R01 MH090326 (to I.V.B.); and the Claflin Distinguished Scholar Award (to I.V.B.). P.K.D., M.R. and I.V.B. designed the study. P.K.D. and M.R. collected and analysed the data. P.K.D. wrote the manuscript. All authors contributed to data interpretation and manuscript revision.

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Medicine and the Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, 02114, Massachusetts, USA

    Paul K. Drain

  2. Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, 02114, Massachusetts, USA

    Marion Robine

  3. Departments of Global Health and Medicine, School of Public Health and Community Medicine, University of Washington, Seattle, 98104, Washington, USA

    King K. Holmes

  4. Division of Infectious Diseases, Department of Medicine and the Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, USA; and at the Center for AIDS Research, Harvard Medical School, Boston, Massachusetts 02114, USA.,

    Ingrid V. Bassett

  5. and at the Center for AIDS Research, Harvard Medical School, Boston, Massachusetts 02114, USA.,

    Ingrid V. Bassett

Authors
  1. Paul K. Drain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marion Robine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. King K. Holmes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ingrid V. Bassett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul K. Drain.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information S1 (box)

Details of data and analysis (PDF 172 kb)

Supplementary information S2 (box)

Supplementary tables (PDF 165 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drain, P., Robine, M., Holmes, K. et al. Global migration of clinical trials. Nat Rev Drug Discov 13, 166–167 (2014). https://doi.org/10.1038/nrd4260

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4260

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing